ArticleFrontiers in medicine2023

Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation.

Julian E Klaas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.